1. Home
  2. DTSS vs IMRN Comparison

DTSS vs IMRN Comparison

Compare DTSS & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

N/A

Current Price

$0.74

Market Cap

8.7M

Sector

Technology

ML Signal

N/A

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$1.18

Market Cap

9.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTSS
IMRN
Founded
2014
1994
Country
China
Australia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
9.6M
IPO Year
2026
2016

Fundamental Metrics

Financial Performance
Metric
DTSS
IMRN
Price
$0.74
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
422.0K
19.2K
Earning Date
05-14-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.68
52 Week High
$2.50
$2.38

Technical Indicators

Market Signals
Indicator
DTSS
IMRN
Relative Strength Index (RSI) 42.33 56.13
Support Level $0.63 $0.98
Resistance Level $0.84 $1.22
Average True Range (ATR) 0.09 0.07
MACD -0.00 0.01
Stochastic Oscillator 21.61 80.00

Price Performance

Historical Comparison
DTSS
IMRN

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: